ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CMPX Compass Therapeutics Inc

1.70
0.05 (3.03%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Compass Therapeutics Inc CMPX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.05 3.03% 1.70 23:00:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.77 1.68 1.79 1.70 1.65
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202407:00GLOBECompass Therapeutics Receives FDA Fast Track Designation for..
16/4/202407:00GLOBECompass Therapeutics Announces First Patient Dosed in the..
12/4/202407:00GLOBECompass Therapeutics Announces Poster Presentations at the..
10/4/202407:00GLOBECompass Therapeutics to Participate in the Stifel Targeted..
09/4/202411:00GLOBECompass Therapeutics Presents Data Demonstrating Elimination..
21/3/202408:00GLOBECompass Therapeutics Reports 2023 Financial Results and..
11/3/202409:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202407:00GLOBECompass Therapeutics to Participate in the Leerink Partners..
28/2/202407:00GLOBECompass Therapeutics Announces Publication of CTX-8371..
14/2/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202411:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202409:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202416:30EDGAR2Form 8-K - Current report
05/1/202407:00EDGAR2Form 8-K - Current report
05/1/202407:00GLOBECompass Therapeutics Provides Corporate Update
21/11/202313:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:30EDGAR2Form 8-K - Current report
09/11/202306:30GLOBECompass Therapeutics Reports Third Quarter 2023 Financial..
07/11/202307:00GLOBECompass Therapeutics to Participate in Upcoming Investor..
30/8/202307:00GLOBECompass Therapeutics to Participate in Upcoming Investor..
03/8/202307:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202307:00EDGAR2Form 8-K - Current report
03/8/202307:00GLOBECompass Therapeutics Reports Second Quarter 2023 Financial..
22/6/202315:05GLOBECompass Therapeutics to be Added to the Russell 2000® and..
01/6/202309:06GLOBECompass Therapeutics to Participate in Upcoming Investor..

Su Consulta Reciente

Delayed Upgrade Clock